Latest Videos

This animation explains how RNAi works and introduces the two main players: small interfering RNAs (siRNAs) and microRNAs (miRNAs).

Salk scientists advance stem-cell and genome-editing technologies to help researchers study evolution and disease, test therapeutic drugs and possibly grow transplantable organs.

Canadian and Australian prostate cancer researchers have discovered a key piece in the genetic puzzle of why men born with a BRCA2 mutation develop aggressive localized cancer that resists treatment and becomes lethal for up to 50% of patients within five years.

In this talk, Matthias Nees discusses the development of cell culture model systems to recapitulate key aspects of cancer progression and to functionally validate biomarkers, target genes, and molecular signaling pathways.

In this talk, James Zhe Liu presents his teams latest efforts in harnessing a set of advanced super-resolution, single-molecule imaging approaches to study how enhancer-binding pluripotency factors (Sox2/Oct4) dynamically search for and assemble on their cognate sites in live embryonic stem (ES) cells.

DNA copy number variations (CNVs) play an important role in the pathogenesis and progression of cancer and confer susceptibility to a variety of human disorders.

Elaine Mardis (Washington University School of Medicine, USA) describes how computational tools are being used to inform therapeutic decisions.

You are two, except only one you is reading this. Confused? Watch to understand.

Your internal army fighting off invasions, sounds simple but the reality is complex and amazing.

Chemists know, wouldn't YOU like to know?